HBSAg Protéines
(Hepatitis B Virus Surface Antigen (HBsAg))
Filtrer les résultats:
25 Résultats
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Mammalian Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
Animal-Free
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Yeast (Hansenula)
VLP
> 95 % (SDS-PAGE)
ELISA, WB, SDS, TEM
1 image
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Levure
Recombinant
> 95 % pure
ELISA
2 références
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Hepatitis B Virus (HBV)
Native
> 95 % pure
1 reference
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Yeast (Saccharomyces Cerevisiae)
Recombinant
95 % by SDS-PAGE
ELISA, WB
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Yeast (Saccharomyces Cerevisiae)
Recombinant
WB, EIA
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Human
Native
>95 %
ELISA
Inactive
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: CHO Cells
Recombinant
>90 %
ELISA
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Human
Native
> 99 % “Ad” subtype purity (ELISA)
EIA
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Yeast (Saccharomyces Cerevisiae)
Recombinant
WB, EIA
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Yeast (Pichia pastoris)
Recombinant
WB, EIA
HBsAg
Origine: Hepatitis B Virus (HBV)
Hôte: Yeast (Saccharomyces Cerevisiae)
Recombinant
> 98 %
EIA
HBsAg
Origine: Hepatitis B Virus (HBV)
Recombinant
> 98 % pure (SDS-PAGE).
ELISA
Dernières publications pour nos HBSAg Protéines
: "Vaccination with a DNA vaccine encoding CD317-targeting HBs antigen elicits enhanced immunity in mice." dans: Biochemical and biophysical research communications, Vol. 504, Issue 4, pp. 865-870, (2019) (PubMed).
: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." dans: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).
: "Induction of Strong and Specific Humoral and T-helper 1 Cellular Responses by HBsAg Entrapped in the Methanobrevibacter smithii Archaeosomes." dans: Avicenna journal of medical biotechnology, Vol. 6, Issue 4, pp. 238-45, (2014) (PubMed).
: "Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-? therapy during pregnancy: three-center study." dans: Scandinavian journal of gastroenterology, Vol. 48, Issue 8, pp. 951-8, (2013) (PubMed).
: "Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array." dans: Journal of immunological methods, Vol. 371, Issue 1-2, pp. 159-64, (2011) (PubMed).
: "Elevated serum IgE prior to acute severe infusion reaction during infliximab maintenance therapy in a Crohn's disease patient." dans: Inflammatory bowel diseases, Vol. 17, Issue 12, pp. E156-7, (2011) (PubMed).
: "Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination." dans: Vaccine, Vol. 28, Issue 21, pp. 3672-8, (2010) (PubMed).
: "Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine." dans: Antiviral research, Vol. 42, Issue 2, pp. 97-108, (1999) (PubMed).
: "Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis." dans: PLoS ONE, Vol. 11, Issue 12, pp. e0167757, (2017) (PubMed).
: "Induction of Strong and Specific Humoral and T-helper 1 Cellular Responses by HBsAg Entrapped in the Methanobrevibacter smithii Archaeosomes." dans: Avicenna journal of medical biotechnology, Vol. 6, Issue 4, pp. 238-45, (2014) (PubMed).
: "Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-? therapy during pregnancy: three-center study." dans: Scandinavian journal of gastroenterology, Vol. 48, Issue 8, pp. 951-8, (2013) (PubMed).
: "Synergetic chemiluminescence and label-free dual detection for developing a hepatitis protein array." dans: Journal of immunological methods, Vol. 371, Issue 1-2, pp. 159-64, (2011) (PubMed).
: "Elevated serum IgE prior to acute severe infusion reaction during infliximab maintenance therapy in a Crohn's disease patient." dans: Inflammatory bowel diseases, Vol. 17, Issue 12, pp. E156-7, (2011) (PubMed).
: "Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination." dans: Vaccine, Vol. 28, Issue 21, pp. 3672-8, (2010) (PubMed).
: "Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine." dans: Antiviral research, Vol. 42, Issue 2, pp. 97-108, (1999) (PubMed).
Avez-vous cherché autre chose?
- HBS1L Protéines
- HBQ1 Protéines
- HBP1 Protéines
- HBG2 Protéines
- HBG1 Protéines
- HBEGF Protéines
- HBd Protéines
- HbA1c Protéines
- HBA1 Protéines
- HAX1 Protéines
- HAUS7 Protéines
- HAUS2 Protéines
- HAUS1 Protéines
- HAT1 Protéines
- HAS3 Protéines
- HAS2 Protéines
- HAS1 Protéines
- HARS2 Protéines
- HARS1/Jo-1 Protéines
- HARBI1 Protéines
- HBXIP Protéines
- HBZ Protéines
- HCCS Protéines
- HCFC1 Protéines
- HCFC1R1 Protéines
- HCFC2 Protéines
- HCK Protéines
- HCLS1 Protéines
- HCN1 Protéines
- HCN2 Protéines
- HCN3 Protéines
- HCN4 Protéines
- HCRTR1 Protéines
- HCRTR2 Protéines
- HCST Protéines
- HCV Core Protein Protéines
- HCV E2 Protéines
- HCV NS3 Protéines
- HDAC1 Protéines
- HDAC10 Protéines
Vous êtes ici:
